TEVA 7389 (Risedronate Sodium 35 mg)
Pill with imprint TEVA 7389 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7389
Risedronate Sodium
- Imprint:
- TEVA 7389
- Strength:
- 35 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- 00093-3098
More about risedronate
- Risedronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 32 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
Other brands: Actonel, Atelvia
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
